IL262716A - Oxidized cellulose preparations - Google Patents

Oxidized cellulose preparations

Info

Publication number
IL262716A
IL262716A IL262716A IL26271618A IL262716A IL 262716 A IL262716 A IL 262716A IL 262716 A IL262716 A IL 262716A IL 26271618 A IL26271618 A IL 26271618A IL 262716 A IL262716 A IL 262716A
Authority
IL
Israel
Prior art keywords
oxidized cellulose
cellulose compositions
compositions
oxidized
cellulose
Prior art date
Application number
IL262716A
Other languages
English (en)
Hebrew (he)
Original Assignee
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omrix Biopharmaceuticals Ltd filed Critical Omrix Biopharmaceuticals Ltd
Priority to IL262716A priority Critical patent/IL262716A/en
Publication of IL262716A publication Critical patent/IL262716A/en
Priority to EP23210952.0A priority patent/EP4327840A3/en
Priority to EP19806061.8A priority patent/EP3873548B1/en
Priority to CA3117353A priority patent/CA3117353A1/en
Priority to BR112021008297-2A priority patent/BR112021008297A2/pt
Priority to KR1020217016577A priority patent/KR102802704B1/ko
Priority to MX2021005146A priority patent/MX2021005146A/es
Priority to US16/668,691 priority patent/US20200139021A1/en
Priority to AU2019373895A priority patent/AU2019373895B2/en
Priority to CN201980072743.0A priority patent/CN112969481A/zh
Priority to ES19806061T priority patent/ES2967597T3/es
Priority to JP2021523733A priority patent/JP7539878B2/ja
Priority to PCT/IL2019/000003 priority patent/WO2020089883A2/en
Priority to US16/866,739 priority patent/US20200261492A1/en
Priority to CONC2021/0005679A priority patent/CO2021005679A2/es
Priority to JP2022567307A priority patent/JP7772381B2/ja
Priority to EP21727946.2A priority patent/EP4146294A1/en
Priority to PCT/IL2021/050513 priority patent/WO2021224919A1/en
Priority to CN202180033290.8A priority patent/CN115515654A/zh
Priority to US18/638,964 priority patent/US20240285834A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0047—Enzymes, e.g. urokinase, streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/424—Anti-adhesion agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL262716A 2018-11-01 2018-11-01 Oxidized cellulose preparations IL262716A (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IL262716A IL262716A (en) 2018-11-01 2018-11-01 Oxidized cellulose preparations
PCT/IL2019/000003 WO2020089883A2 (en) 2018-11-01 2019-10-30 Compositions comprising oxidized cellulose
AU2019373895A AU2019373895B2 (en) 2018-11-01 2019-10-30 Compositions comprising oxidized cellulose
ES19806061T ES2967597T3 (es) 2018-11-01 2019-10-30 Composiciones que comprenden celulosa oxidada
CA3117353A CA3117353A1 (en) 2018-11-01 2019-10-30 Compositions comprising oxidized cellulose
BR112021008297-2A BR112021008297A2 (pt) 2018-11-01 2019-10-30 composições que compreendem celulose oxidada
KR1020217016577A KR102802704B1 (ko) 2018-11-01 2019-10-30 산화 셀룰로오스를 포함하는 조성물
MX2021005146A MX2021005146A (es) 2018-11-01 2019-10-30 Composiciones que comprenden celulosa oxidada.
US16/668,691 US20200139021A1 (en) 2018-11-01 2019-10-30 Compositions Comprising Oxidized Cellulose
EP23210952.0A EP4327840A3 (en) 2018-11-01 2019-10-30 Compositions comprising oxidized cellulose
CN201980072743.0A CN112969481A (zh) 2018-11-01 2019-10-30 包含氧化纤维素的组合物
EP19806061.8A EP3873548B1 (en) 2018-11-01 2019-10-30 Compositions comprising oxidized cellulose
JP2021523733A JP7539878B2 (ja) 2018-11-01 2019-10-30 酸化セルロースを含む組成物
US16/866,739 US20200261492A1 (en) 2018-11-01 2020-05-05 Compositions Comprising Oxidized Cellulose
CONC2021/0005679A CO2021005679A2 (es) 2018-11-01 2021-04-29 Composiciones que comprenden celulosa oxidada
JP2022567307A JP7772381B2 (ja) 2018-11-01 2021-05-03 酸化セルロースを含む組成物
EP21727946.2A EP4146294A1 (en) 2018-11-01 2021-05-03 Compositions comprising oxidized cellulose
PCT/IL2021/050513 WO2021224919A1 (en) 2018-11-01 2021-05-03 Compositions comprising oxidized cellulose
CN202180033290.8A CN115515654A (zh) 2018-11-01 2021-05-03 包含氧化纤维素的组合物
US18/638,964 US20240285834A1 (en) 2018-11-01 2024-04-18 Compositions Comprising Oxidized Cellulose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL262716A IL262716A (en) 2018-11-01 2018-11-01 Oxidized cellulose preparations

Publications (1)

Publication Number Publication Date
IL262716A true IL262716A (en) 2018-11-29

Family

ID=66624699

Family Applications (1)

Application Number Title Priority Date Filing Date
IL262716A IL262716A (en) 2018-11-01 2018-11-01 Oxidized cellulose preparations

Country Status (13)

Country Link
US (3) US20200139021A1 (enExample)
EP (3) EP3873548B1 (enExample)
JP (2) JP7539878B2 (enExample)
KR (1) KR102802704B1 (enExample)
CN (2) CN112969481A (enExample)
AU (1) AU2019373895B2 (enExample)
BR (1) BR112021008297A2 (enExample)
CA (1) CA3117353A1 (enExample)
CO (1) CO2021005679A2 (enExample)
ES (1) ES2967597T3 (enExample)
IL (1) IL262716A (enExample)
MX (1) MX2021005146A (enExample)
WO (2) WO2020089883A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
JP2024500994A (ja) 2020-12-28 2024-01-10 デボル，インコーポレイテッド タンパク質及び多官能化変性ポリエチレングリコール系架橋剤を含む反応性乾燥粉末状止血用材料
CN117320763A (zh) * 2021-02-16 2023-12-29 康奈尔大学 多糖-甘油抗穿透性组合物和由其制备的手术屏障
WO2022217492A1 (en) 2021-04-14 2022-10-20 Guangzhou Bioseal Biotech Co., Ltd. Flowable hemostatic paste
GB2636872A (en) * 2023-12-29 2025-07-02 Futamura Chemical Uk Ltd Composition

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3122479A (en) * 1957-11-14 1964-02-25 David F Smith Hemostatic surgical dressings
US3364200A (en) 1960-03-28 1968-01-16 Johnson & Johnson Oxidized cellulose product and method for preparing the same
US4668224A (en) * 1983-10-24 1987-05-26 Warner-Lambert Company Oxidized cellulose as a medical lubricant
US4626253A (en) 1984-10-05 1986-12-02 Johnson & Johnson Products, Inc. Surgical hemostat comprising oxidized cellulose
US5002551A (en) 1985-08-22 1991-03-26 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US5007916A (en) 1985-08-22 1991-04-16 Johnson & Johnson Medical, Inc. Method and material for prevention of surgical adhesions
US4696812A (en) * 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
US5134229A (en) * 1990-01-12 1992-07-28 Johnson & Johnson Medical, Inc. Process for preparing a neutralized oxidized cellulose product and its method of use
US5180398A (en) 1990-12-20 1993-01-19 Johnson & Johnson Medical, Inc. Cellulose oxidation by a perfluorinated hydrocarbon solution of nitrogen dioxide
CA2060223C (en) * 1991-02-12 1999-07-20 Clarence C. Lee Injectable medical lubricating fluid composition and method of use
US5266624A (en) * 1992-07-20 1993-11-30 Isp Investments Inc. High load polymer pastes as pharmaceutical adhesives
CZ288792B6 (cs) * 1993-12-23 2001-09-12 Johnson & Johnson Medical, Inc. Bioabsorbovatelný chirurgický hemostat a způsob jeho výroby
US5696101A (en) * 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
US20030073663A1 (en) * 1997-06-25 2003-04-17 David M Wiseman Bioabsorbable medical devices from oxidized polysaccharides
US6627749B1 (en) 1999-11-12 2003-09-30 University Of Iowa Research Foundation Powdered oxidized cellulose
AU784607B2 (en) * 2000-05-12 2006-05-11 Systagenix Wound Management Ip Co. B.V. Free radical scavenging compositions
JP2003024431A (ja) * 2001-07-18 2003-01-28 Kuraray Co Ltd 癒着防止材およびその製造方法
EP1601388B1 (en) * 2003-03-10 2011-04-27 Johnson & Johnson Medical Ltd. Hydrocolloid materials for use in wound healing
US20040265371A1 (en) 2003-06-25 2004-12-30 Looney Dwayne Lee Hemostatic devices and methods of making same
CN101052360B (zh) * 2003-09-23 2012-05-16 奥索康公司 可吸收的植入体和它们用于止血和治疗骨缺损的方法
US7109163B2 (en) * 2004-01-30 2006-09-19 Ethicon, Inc. Hemostatic compositions and devices
JP2008505680A (ja) * 2004-07-08 2008-02-28 オールトレイセル・ディベロップメント・サービシズ・リミテッド 皮膚の創傷の出血を制御するための送達システム
WO2007106251A1 (en) * 2006-03-13 2007-09-20 Xylos Corporation Oxidized microbial cellulose and use thereof
CN104888264B (zh) * 2008-01-14 2018-01-09 北京环球利康科技有限公司 生物相容性止血、防粘连、促愈合、外科封闭的变性淀粉材料
US9572907B2 (en) 2010-10-01 2017-02-21 Covidien Lp Implantable polymeric films
US20130084324A1 (en) 2011-09-30 2013-04-04 Michel Gensini Adhesion prevention fabric
AU2012318258B2 (en) * 2011-10-11 2015-07-09 Baxter Healthcare S.A. Hemostatic compositions
US8815832B2 (en) * 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
US9447196B2 (en) 2012-06-28 2016-09-20 Covidien Lp Dissolution of oxidized cellulose and particle preparation by solvent and non-solvent precipitation
US10111980B2 (en) * 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
PE20180230A1 (es) 2015-02-16 2018-01-31 Petro Andriyovych Manoryk Composicion hemostatica y dispositivo hemostatico (variantes)
US10172617B2 (en) * 2015-03-25 2019-01-08 Ethicon Llc Malleable bioabsorbable polymer adhesive for releasably attaching a staple buttress to a surgical stapler
BR112018008895B1 (pt) 2015-11-06 2021-11-16 Ethicon, Inc. Agregados hemostáticos e método para sua produção
WO2017077525A1 (en) 2015-11-08 2017-05-11 Omrix Biopharmaceuticals Ltd. Hemostatic composition
CN105536039A (zh) * 2015-12-25 2016-05-04 北京大清生物技术有限公司 一种可吸收流体止血材料及其制备方法与应用
WO2018049059A1 (en) * 2016-09-07 2018-03-15 Blood Brothers, LLC Hemostatic paste with light-curable feature

Also Published As

Publication number Publication date
EP4146294A1 (en) 2023-03-15
BR112021008297A2 (pt) 2021-08-03
WO2020089883A3 (en) 2020-06-18
US20200139021A1 (en) 2020-05-07
WO2021224919A1 (en) 2021-11-11
JP2022509912A (ja) 2022-01-25
EP4327840A3 (en) 2024-05-22
EP3873548B1 (en) 2023-11-29
WO2020089883A2 (en) 2020-05-07
ES2967597T3 (es) 2024-05-03
EP4327840A2 (en) 2024-02-28
US20200261492A1 (en) 2020-08-20
JP2023524137A (ja) 2023-06-08
CA3117353A1 (en) 2020-05-07
CN112969481A (zh) 2021-06-15
JP7772381B2 (ja) 2025-11-18
EP3873548C0 (en) 2023-11-29
EP3873548A2 (en) 2021-09-08
KR102802704B1 (ko) 2025-05-08
AU2019373895A1 (en) 2021-05-20
CO2021005679A2 (es) 2021-05-10
MX2021005146A (es) 2021-07-15
AU2019373895B2 (en) 2025-02-20
KR20210089694A (ko) 2021-07-16
US20240285834A1 (en) 2024-08-29
CN115515654A (zh) 2022-12-23
JP7539878B2 (ja) 2024-08-26

Similar Documents

Publication Publication Date Title
GB201811312D0 (en) Compositions
GB2586745B (en) Compositions
GB201916960D0 (en) Compositions
SG11202104306XA (en) Compositions
DK3924442T3 (en) Compositions
IL262716A (en) Oxidized cellulose preparations
SG11202009259VA (en) Compositions
GB201810492D0 (en) Composition
IL289125A (en) the vehicles
GB201811100D0 (en) Composition
GB201804434D0 (en) Composition
GB201908396D0 (en) Compositions
GB201803923D0 (en) Compositions
GB2572364B (en) Improved Bleaching Compositions
EP3638728C0 (en) CELLULOSE-BASED COMPOSITION
GB201801596D0 (en) Composition
GB201805676D0 (en) Compositions
GB201810024D0 (en) Composition
GB201919234D0 (en) Compositions
GB201916122D0 (en) New compositions
GB2570649B (en) Compositions
GB201809123D0 (en) Composition
ZA202005658B (en) Compositions
GB201916130D0 (en) New compositions
GB201916117D0 (en) New compositions